Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

Florence Duffaud; Caroline Even; Isabelle Ray-Coquard; Emmanuelle Bompas; Thanh Khoa-Huynh; Sebastien Salas; Philippe Cassier; Armelle Dufresne; Sylvie Bonvalot; Francoise Ducimetiere; Axel Le Cesne; Jean-Yves Blay

首页> 外文期刊>Clinical Sarcoma Research >Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

【24h】

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

机译：重组促红细胞生成素用于接受伊马替尼的晚期胃肠道间质瘤（GIST）患者的贫血：仅对非进行性患者有效

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib : an active agent only in non progressive patients.

机译：重组促红细胞生成素用于接受伊马替尼的晚期胃肠道间质瘤（GIST）患者的贫血：仅在非进行性患者中有效。

著录项

来源
《Clinical Sarcoma Research》 |2012年第4期|共页
作者
Florence Duffaud; Caroline Even; Isabelle Ray-Coquard; Emmanuelle Bompas; Thanh Khoa-Huynh; Sebastien Salas; Philippe Cassier; Armelle Dufresne; Sylvie Bonvalot; Francoise Ducimetiere; Axel Le Cesne; Jean-Yves Blay;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib na?ve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: Relation to tumour-biological risk-profile and long-term outcome [J] . S?reideK., SandvikO.M., S?reideJ.A., Clinical & translational oncology : . 2012,第8期

机译：伊马替尼幼年成年胃和小肠胃肠道间质瘤（GIST）患者的c-KIT和PDGFR-alpha基因酪氨酸激酶突变：与肿瘤生物学风险谱和长期预后的关系
2. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome [J] . Kjetil Søreide, Oddvar M. Sandvik, Jon Arne Søreide, Clinical and Translational Oncology . 2012,第8期

机译：伊马替尼未成年胃和小肠胃肠道间质瘤（GIST）的成年患者c-KIT和PDGFR-alpha基因中的酪氨酸激酶突变：与肿瘤生物学风险谱和长期预后的关系
3. 7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable or metastatic gastrointestinal stromal tumors (GISTs) [J] . H.Joensuu, G.D.Demetri, M.C.Heinrich, European Journal of Cancer Supplements . 2007,第4期

机译：7506口服接受甲磺酸伊马替尼（Glivec）治疗无法切除或转移性胃肠道间质瘤（GIST）的患者的长达6年的随访
4. Efficacy of Intraperitoneal Perfusion Hyperthermic Chemotheraphy(CHIP)With Cisplatin Combined With Intraveuous Chemotherapy for Patients With Advanced Gastrointestinal Carcinoma [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：腹腔灌注热化学疗法（CHIP）联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
5. Impact of Erythropoiesis Stimulating Agents on Survival and Risk of Venous Thromboembolism Among Patients with Colorectal Cancer Receiving Chemotherapy. [D] . Sato, Masayo. 2012

机译：红细胞生成刺激剂对接受化疗的结直肠癌患者生存率和静脉血栓栓塞风险的影响。
6. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients [O] . Florence Duffaud, Caroline Even, Isabelle Ray-Coquard, 2012

机译：重组促红细胞生成素用于接受伊马替尼的晚期胃肠道间质瘤（GIST）患者的贫血：一种仅在非进行性患者中的活性药物
7. Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients [O] . 2012

机译：重组促红细胞生成素用于接受伊马替尼的晚期胃肠道间质瘤（GIST）患者的贫血：一种仅在非进行性患者中的活性药物

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

摘要

著录项

相似文献

相关主题

期刊订阅